Neuropeptide release influences brain edema formation after diffuse traumatic brain injury

Acta Neurochir Suppl. 2003:86:257-60. doi: 10.1007/978-3-7091-0651-8_55.

Abstract

The mechanisms associated with edema formation after traumatic brain injury (TBI) have not been fully elucidated. In peripheral tissue injury, the neurogenic component of inflammation plays a significant role in increased vascular permeability and edema formation. However, few studies have examined the role of neuropeptide induced neurogenic inflammation following TBI. Adult male Sprague-Dawley rats were either left untreated, or pre-treated with capsaicin (125 mg/kg s.c.) or equal volume vehicle, and injured 14 days later using the 2-meter impact-acceleration model. Subgroups of animals were assessed for blood brain barrier (BBB) permeability (Evans Blue), brain edema (wet weight/dry weight) and functional outcome (Barnes maze and Rotarod) for up to 2 weeks post-trauma. Increased BBB permeability was present in untreated animals between 3 and 6 h after injury but not at later time-points. Edema was maximal at 5 h after trauma, declined and then significantly increased over the 5 days post-trauma. In contrast, capsaicin pre-treated, neuropeptide-depleted animals exhibited no significant increase in BBB permeability or edema compared to vehicle treated animals after injury. Notably, motor and cognitive impairments were significantly reduced in the capsaicin-pretreated animals. We conclude that neurogenic inflammation contributes to the development of edema and posttraumatic deficits after diffuse TBI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood-Brain Barrier / drug effects
  • Brain Edema / etiology*
  • Brain Injuries / complications*
  • Brain Injuries / metabolism*
  • Brain Injuries / physiopathology
  • Capillary Permeability / drug effects
  • Capsaicin / pharmacology
  • Cognition / drug effects
  • Cognition Disorders / prevention & control
  • Male
  • Motor Activity / drug effects
  • Movement Disorders / prevention & control
  • Neuropeptides / metabolism*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Neuropeptides
  • Capsaicin